ARASH ALIPOUR: Open Payments
NPI 1851618334 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 45 payments from 8 companies in 2025. Trend: 2023 $1,214 · 2024 $903 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $368 |
| PFIZER INC. | 11 | $230 |
| Electronic Waveform Lab, Inc. | 12 | $148 |
| Virtus Pharmaceuticals LLC | 2 | $49 |
| Lilly USA, LLC | 1 | $33 |
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 1 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| Boston Scientific Corporation | 1 | $15 |
Products named: NURTEC ODT, QULIPTA, UBRELVY, LEVORPHANOL TARTRATE, ZEPBOUND, RS-4i Plus with Intersperse, Wegovy, BOTOX.
Industry payments across CA — which companies pay providers there.
